Latest Marketable Securities News

Page 1 of 10
Everpure delivered a sharp acceleration in fiscal Q3, with revenue rising 51% to US$1.46 billion and management lifting its full-year targets for the third consecutive quarter. Subscription growth, AI infrastructure demand and a second top-five hyperscaler design win strengthened the company’s growth narrative.
Sophie Babbage
Sophie Babbage
19 Nov 2026
EBR Systems delivered higher reimbursement, manufacturing and revenue milestones in the third quarter, but a sharp September slowdown and a formal going-concern warning have shifted attention to execution and funding. The company says it holds US$93.2 million in cash, cash equivalents and marketable securities, while US$41.8 million of debt falls due within 12 months.
Victor Sage
Victor Sage
10 Nov 2026
Novo Resources is using an A$37.69 million investment portfolio and about A$8.5 million in cash to fund a broad gold, copper and polymetallic exploration strategy. The opportunity is substantial, but so is the December A$10 million deferred payment and the need to convert conceptual targets into resources.
Maxwell Dee
Maxwell Dee
10 Nov 2026
Novo Resources reduced its nine-month loss and operating cash burn, while a C$16.4 million revaluation of its San Cristobal Mining investment lifted marketable securities to C$37.8 million. The stronger balance sheet still faces a major test in December, when approximately A$10 million of deferred consideration falls due.
Maxwell Dee
Maxwell Dee
9 Nov 2026
AVITA Medical has raised its 2026 revenue guidance for a second time after third-quarter revenue climbed 53% year on year. The company also drew a further US$10 million under its credit facility and removed its going-concern qualification, although it remains loss-making and highly leveraged.
Victor Sage
Victor Sage
6 Nov 2026
Akamai delivered solid third-quarter revenue growth, led by a 34% jump in Cloud Infrastructure Services, but profitability and margins declined. The company is now projecting a sharp acceleration in 2027 and revenue above US$7 billion in 2028.
Sophie Babbage
Sophie Babbage
6 Nov 2026
Datadog delivered another strong quarter, with revenue up 35% and large-customer growth supporting its push into AI-powered observability. The company also issued fourth-quarter and full-year guidance while launching Scout 1.0, its first specialised AI model.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Arista Networks delivered third-quarter revenue well above its own guidance, with sales reaching US$3.66 billion and GAAP net income hitting US$1.56 billion. The networking specialist is now guiding to as much as US$4.0 billion in fourth-quarter revenue as it expands its AI infrastructure portfolio.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Vertex has raised its full-year 2026 revenue guidance after third-quarter sales climbed 12%, but the Crinetics acquisition sharply increased costs and debt. The next major test arrives on 30 November, when US regulators are due to rule on povetacicept for IgA nephropathy.
Ada Torres
Ada Torres
3 Nov 2026
Orion Equities will ask shareholders to approve a voluntary ASX delisting, arguing that sparse trading, concentrated ownership and annual listing costs no longer justify its quoted status. The move would leave shareholders relying on private transactions to sell their shares if the delisting proceeds.
Claire Turing
Claire Turing
26 Oct 2026
Mayne Pharma’s unaudited first-quarter revenue fell 2% to A$95.7 million, while underlying EBITDA dropped 52% as generic competition hit Dermatology. Strong prescription growth in Women’s Health and DistributeRx offered a partial counterweight, alongside progress on key legal disputes.
Victor Sage
Victor Sage
26 Oct 2026
Bailador Technology Investments reported $28 million in FY26 cash realisations and 32% weighted revenue growth across its portfolio, while profit after tax fell to $6.9 million. The technology investment fund also reaffirmed its fully franked dividend strategy despite a 7.5% gross portfolio return that fell short of internal targets.
Claire Turing
Claire Turing
13 Oct 2026

Browse the archive

Full archive